Encysive Pharmaceuticals
Encysive Pharmaceuticals develops synthetic and small molecule compounds to address medical needs worldwide.
Business Model:
Revenue: $0
Employees: 51-500
Rankings
Industries / Tags:
Detailed Encysive Pharmaceuticals Information
Encysive Pharmaceuticals was acquired by
Pfizer.
The acquisition happend on 2008-02-20.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Houston
State: Texas
Zip:
Country: United States
Financial Info
Stage:
private equity
Raised Last:
$14M
Raised Total:$89M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Encysive Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes synthetic and small molecule compounds to address medical needs worldwide. The company focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade, and vascular diseases. Its products include Argatroban for the treatment of heparin-induced thrombocytopenia; and Thelin (sitaxsentan sodium), an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension, congestive heart failure, and essential hypertension. The company&s;s clinical development compounds include TBC3711, an endothelin receptor antagonist; TBC4746, an antigen-4 antagonist; ENC8003, a G protein-coupled receptor; and bimosiamose, a selectin antagonist. Encysive Pharmaceuticals has research collaboration and license agreements with GlaxoSmithKline plc; Mitsubishi Pharma Corporation; Schering-Plough, Ltd.; Schering Corporation; and Revotar Biopharmaceuticals, AG. The company was founded in 1989. It was formerly known as Texas Biotechnology Corporation and changed its name to Encysive Pharmaceuticals, Inc. in 2003. Encysive Pharmaceuticals is based in Houston, Texas. As of June 10, 2008, Encysive Pharmaceuticals Inc. operates as a subsidiary of Pfizer Inc.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2006 | Private Equity Round | 1 | $75M |
Azimuth Opportunity Azimuth Opportunity |
8/2007 | Private Equity Round | $0 |
Enable Capital Management Hudson Capital Group Enable Capital Management Hudson Capital Group |
8/2007 | Private Equity Round | 2 | $13.9M |
Enable Capital Management Hudson Capital Group Enable Capital Management Hudson Capital Group |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
